Genome-wide gene expression profiling of ischemia-reperfusion injury in rat kidney, intestine and skeletal muscle implicate a common involvement of MAPK signaling pathway

Molecular Medicine Reports

Volumn 11, Issue 5, 2015, Pages 3786-3793

  Chang, Nai Jen ^a,b   Weng, Wen Hui ^c   Chang, Kuo Hsuan ^a,b   Liu, Eric Kar Wai ^a,b   Chuang, Cheng Keng ^a,b   Luo, Chih Cheng ^d   Lin, Cheng Hung ^a,b   Wei, Fu Chan ^a,b   Pang, See Tong ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Activator protein 1; Different organs; Ischemia reperfusion injury; MAPK pathway; NF B pathway

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUN; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; INTESTINE ISCHEMIA; KIDNEY; KIDNEY ISCHEMIA; MALE; MUSCLE ISCHEMIA; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMALL INTESTINE; UPREGULATION; ANIMAL; ANTIBODY SPECIFICITY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; INTESTINE; METABOLISM; REPRODUCIBILITY;

RATTUS;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; INTESTINES; KIDNEY; MALE; MAP KINASE SIGNALING SYSTEM; MUSCLE, SKELETAL; ORGAN SPECIFICITY; RATS; REPERFUSION INJURY; REPRODUCIBILITY OF RESULTS; TRANSCRIPTOME;

EID: 84922287237     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3235     Document Type: Article

References (34)

1. Ames A: Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 52: 437, 1968.
2. Hsieh Y-H, Huang S-S, Wei F-C and Hung L-M: Resveratrol attenuates ischemia - reperfusion-induced leukocyte - endothelial cell adhesive interactions and prolongs allograft survival across the MHC barrier. Circ J 71: 423-428, 2007.
3. Wei W, Wei FC and Hung L-M: Diazoxide ameliorates microcirculatory disturbances through PKC-dependent pathway in I/R-injured rat cremaster muscles. J Biomed Sci 12: 521-529, 2005.
4. Kobrin SM: Diabetic nephropathy. Dis Mon 44: 214-234, 1998.
5. Shihab FS: Cyclosporine nephropathy: pathophysiology and clinical impact. Semin Nephrol 16: 536-547, 1996.
6. Wu X, Pang ST, Sahlin L, et al: Gene expression profiling of the effects of castration and estrogen treatment in the rat uterus. Biol Reprod 69: 1308-1317, 2003.
7. Pang ST, Dillner K, Wu X, et al: Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology 143: 4897-4906, 2002.
8. Wu MS, Yang CW, Chang CT, Bens M and Vandewalle A: Cyclosporin increases the density of angiotensin II subtype 1 (AT1) receptors in mouse medullary thick ascending limb cells. Nephrol Dial Transplant 18: 1458-1465, 2003.
9. Wu MS, Bens M, Yu HM and Vandewalle A: Cyclosporine reduces basolateral, but not apical, nitric oxide secretion in medullary thick ascending limb cells. Transpl Int 13: S321-S323 2000.
10. Mason J: The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr Nephrol 4: 554-574, 1990.
11. Luo CC, Chen HM, Chiu CH, Lin JN and Chen JC: Effect of N(G)-nitro-L-arginine methyl ester on intestinal permeability following intestinal ischemia-reperfusion injury in a rat model. Biol Neonate 80: 60-63, 2001.
12. Basile DP, Fredrich K, Alausa M, et al: Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol 288: F953-F963, 2005.
13. François M, Caprini A, Hosking B, et al: Sox18 induces development of the lymphatic vasculature in mice. Nature 456: 643-647, 2008.
14. Liang Q, Wiese RJ, Bueno OF, et al: The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1-and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 21: 7460-7469, 2001.
15. Park M-T, Choi J-A, Kim M-J, et al: Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8-and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J Biol Chem 278: 50624-50634, 2003.
16. Basile DP, Fredrich K, Chelladurai B, Leonard EC and Parrish AR: Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J Physiol Renal Physiol 294: F928-F936, 2008.
17. Skubitz KM and Skubitz A: Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells. J Transl Med 6: 78, 2008.
18. Qi M and Elion EA: MAP kinase pathways. J Cell Sci 118: 3569-3572, 2005.
19. Mullonkal CJ and Toledo-Pereyra LH: Akt in ischemia and reperfusion. J Invest Surg 20: 195-203, 2007.
20. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995.
21. Shaulian E and Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-136, 2002.
22. Halloran PF: Immunosuppressive drugs for kidney transplantation. N Engl J Med 351: 2715-2729, 2004.
23. Yeh KY, Yeh M, Glass J and Granger DN: Rapid activation of NF-kappaB and AP-1 and target gene expression in postischemic rat intestine. Gastroenterology 118: 525-534, 2000.
24. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486, 1995.
25. Shima Y, Tajiri T, Taguchi T and Suita S: Increased expression of c-fos and c-jun in the rat small intestinal epithelium after ischemia-reperfusion injury: a possible correlation with the proliferation or apoptosis of intestinal epithelial cells. J Pediatr Surg 41: 830-836, 2006.
26. Hai T and Hartman MG: The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273: 1-11, 2001.
27. Ameyar M, Wisniewska M and Weitzman JB: A role for AP-1 in apoptosis: the case for and against. Biochimie 85: 747-752, 2003.
28. Kang Y, Chen C-R and Massagué J: A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 11: 915-926, 2003.
29. Weng Y, Shen F, Li J, Shen Y and Zhang X: Expression changes of mitogen-activated protein kinase phosphatase-1 (MKP-1) in myocardium of streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes 115: 455-460, 2007.
30. Yoshimoto T, Fukai N, Sato R, et al: Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 145: 3331-3337, 2004.
31. Chen J, Crispín JC, Tedder TF, Dalle Lucca J and Tsokos GC: B cells contribute to ischemia/reperfusion-mediated tissue injury. J Autoimmun 32: 195-200, 2009.
32. Liu L, Sakai T, Sano N and Fukui K: Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling. Biochem J 380: 31-41, 2004.
33. Malek HA and Saleh DM: Cyclooxygenase-2 inhibitor celecoxib in a rat model of hindlimb ischemia reperfusion. Can J Physiol Pharmacol 87: 353-359, 2009.
34. Hollander MC, Poola-Kella S and Fornace AJ: Gadd34 functional domains involved in growth suppression and apoptosis. Oncogene 22: 3827-3832, 2003.